Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02926365
Other study ID # EPN DNR 2016/1355-31/5
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2016
Est. completion date December 2022

Study information

Verified date October 2023
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test internet-delivered cognitive behavior therapy for children and adolescents with anxiety disorders and obsessive-compulsive disorder in a routine clinical setting in a rural part of Sweden.


Description:

Aim The aim of this study is to conduct a pragmatic evaluation of ICBT for children and adolescents with anxiety disorders and OCD within routine health care in a rural area. Research questions - Is ICBT an acceptable method for the patient group? - Is ICBT effective in a clinical setting? - Is further treatment needed after ICBT? - What are the long-term effects of ICBT? - What predicts treatment outcome? - How does ICBT work in a clincal setting? (time spent, negative effects etc)? Design This is a uncontrolled intervention study where included families and children will be recruited consecutively during two years from a routine care CAMHS unit. All participants will be offered ICBT and assessed pre- and post-treatment, and at three-month follow-up through clinician ratings and self-report measures. The primary outcome measure is clinician rated severity of principal disorder at three-month follow-up. Long-term results will be assessed through study of medical records two years after completed ICBT.


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date December 2022
Est. primary completion date April 2019
Accepts healthy volunteers No
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria: - Fulfills diagnostic criteria for an anxiety disorder or OCD - Access to a computer and internet connection - Read and speak Swedish Exclusion Criteria: - ICBT is currently not assessed to be a suitable treatment - Acute psychiatric problem (eg. severe depression or suicidality) - Current psychosocial problems in the family (i.e substance abuse, abuse, neglect)

Study Design


Intervention

Behavioral:
ICBT


Locations

Country Name City State
Sweden BUP Jämtland Härjedalen Östersund Region Jämtland Härjedalen

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary CGI-S Clinical Global Impression - Severity 24 weeks from baseline
Secondary CGI-S Clinical Global Impression - Severity 12 weeks from baseline
Secondary CGI-I Clinical Global Impression - Improvement 12 and 24 weeks from baseline
Secondary CGAS Children's Global Assessment Scale 12 and 24 weeks from baseline
Secondary CY-BOCS Children's Yale Brown Obsessive Compulsive Scale 12 and 24 weeks from baseline
Secondary RCADS Revised Children's Anxiety and Depression Scale 12 and 24 weeks from baseline
Secondary EWSAS Education, Work and Social Adjustment Scale - Child and parent versions Week 1 through 12 + 24 weeks from baseline
Secondary Patient satisfaction Questionnaire on child- and parent rated treatment satisfaction 12 weeks from baseline
Secondary Adverse events Unintended treatment effects - child and parent version 12 weeks from baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04934007 - Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder N/A
Recruiting NCT04071990 - Family Involvement in CBGT of OCD: a Randomized Controlled Trial N/A
Completed NCT02541968 - Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Recruiting NCT05391503 - Light Therapy for Obsessive-compulsive Disorder (OCD) N/A
Recruiting NCT04539951 - Pragmatic Trial of Obsessive-compulsive Disorder Phase 2
Completed NCT03416504 - Methods for Managing Intrusive Thoughts N/A
Not yet recruiting NCT06029738 - Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD N/A
Recruiting NCT02844049 - European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS N/A
Completed NCT02911324 - Cannabinoid Medication for Adults With OCD Phase 1/Phase 2
Terminated NCT02909660 - What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder N/A
Terminated NCT02234011 - A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder Phase 2
Completed NCT02217995 - Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients N/A
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02655926 - Deep Brain Stimulation for Severe Obsessive Compulsive Disorder N/A
Terminated NCT00758966 - Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder Phase 2
Completed NCT00742664 - Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project Phase 1/Phase 2
Completed NCT04919785 - Deep Brain Stimulation in Severe Obsessive-compulsive Disorder N/A
Completed NCT00523718 - Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Phase 2
Completed NCT00074815 - Treatment of Obsessive Compulsive Disorder in Children Phase 3